SonoCine® AWBUS
Revolutionizing breast care from reactive to proactive,
with early detection of breast cancer
What is SonoCine AWBUS?
The SonoCine Automated Whole Breast Ultrasound (AWBUS) is an FDA-cleared computer-guided ultrasound supplemental screening designed for early detection of breast cancer. SonoCine AWBUS is ideal for all women, including women with dense breasts, women with implants, and those who have had any type of breast intervention such as a biopsy, lumpectomy, mastectomy. Unlike handheld ultrasound examinations, SonoCine AWBUS exam provides whole breast coverage, including lower axillary lymph nodes, far medial, infra-clavicular, and infra-mammary. SonoCine AWBUS provides greater visual detail of breast tissue where mammograms may have difficulty providing clear, detailed images.
How accurate is SonoCine AWBUS™?
In clinical trials, Breast cancer detection doubled from 23 to 46 in 6,425 studies using AWBU with mammography, resulting in an increase in diagnostic yield from 3.6 per 1,000 with mammography alone to 7.2 per 1,000 by adding AWBU. The number of detected invasive cancers 10 mm or less in size tripled from 7 to 21 when AWBU findings were added to mammography. Conclusion: AWBU resulted in significant cancer detection improvement compared with mammography alone (Kelly et. al., 2009).
Patient experience during SonoCine AWBUS™ exam
When the exam is completed, the SonoCine AWBUS™ technology will have captured between 2,000 and 5,000 images to form an ultrasound movie, or Sono (sound)…Cine (movie), for the Radiologist to review. Unlike others, the SonoCine AWBUS™ is designed to equip healthcare providers with a fully documented, quality controlled examination of the patient’s breast tissue. This way healthcare providers can compare last year’s exam to this year’s exam, to see what changes may have occurred.
Precision/Automation
Technology
SonoCine AWBUS™ robotics automates the scan acquisition process by compensating for sonographer probe manipulation and reducing human error. Robotics assists in maintaining scan-row overlap, and provides automated nipple location, with intuitive, touch-based workflow integrated into RIS and PACS.
SonoCiné captures a slice every 800µ, and thereby provides enough images to identify masses as small as 5mm in diameter. Fluid video playback and visual navigation allow doctors a more comprehensive view of a possible finding.
Source: sonocine.com
SonoCine results that can lead to early detection
A blinded, prospective, clinical trial demonstrated that by adding a blinded AWBUS exam to a mammogram, more smaller cancers were found than by mammography alone.
Source: European Radiology, 10 March, 2010.
Kevin Kelly Multi-Center Trial
- 6,425 exams
- 46 total cancers found
- 39 invasive and 7 DCIS
- 23 cancers visualized by mammography
- 15 cancers visualized by both SonoCine and mammography
- 23 cancers visualized only by SonoCine
Multi-Center-Trial-On-line-Sept-2009-in-EurRadiology
Reader-Trial-July-2010-in-EurRadiology
Abstract-Belinda-Barclay-White-11-28-11
Source: sonocine.com
Why work with us
Early detection is a critical aspect of effectively managing breast cancer, as it allows for timely intervention and improves the chances of successful treatment. SonoCine Automated Whole Breast Ultrasound (AWBUS) is an advanced imaging technology that offers numerous benefits in the early detection of breast cancer.
The Exam Process
SonoCine AWBUS provides a consistent, repeatable scan of the whole breast including the axilla (underarm/lymph nodes). Clinical studies show that adding SonoCine to a yearly mammogram can improve cancer detection results. The SonoCine Method has three steps:
